Elicera cleared to use highest ELC-301 dose before Phase IIa
Elicera Therapeutics AB received clearance to use the highest ELC-301 dose ahead of Phase IIa.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.